JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meulen, E F J
Right arrow Articles by Verhey, F R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meulen, E F J
Right arrow Articles by Verhey, F R
Journal of Neurology Neurosurgery and Psychiatry 2004;75:700-705
© 2004 BMJ Publishing Group Ltd


PAPER

The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia

E F J Meulen1, B Schmand2, J P van Campen1, S J de Koning1, R W Ponds3, P Scheltens4, F R Verhey3

1 Departments of Clinical Geriatrics and Medical Psychology, General Hospital Slotervaart, Slotervaart, Netherlands
2 Departments of Neurology and Psychology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands
3 Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, Limburg, Netherlands
4 Department of Neurology, Vrije Universiteit Medical Centre, Amsterdam

Correspondence to:
Correspondence to:
Dr Etienne Meulen
Department of Clinical Geriatrics, Monsterseweg 89, 2553 RJ The Hague, Netherlands; efjmeulen{at}hotmail.com

Background: The seven minute screen (7MS) is a compilation of the temporal orientation test, enhanced cued recall, clock drawing, and verbal fluency. It has been shown to be useful for detecting Alzheimer’s disease in a population of patients with memory complaints.

Objective: To assess the predictive validity of the 7MS for various types of dementia, and the influence of depression and other psychiatric conditions on 7MS scores.

Setting: Multicentre: secondary referral sites across the Netherlands.

Subjects: 542 patients with various types of dementia or depression, together with 45 healthy controls.

Results: Alzheimer’s disease was diagnosed in 177 patients, other types of dementia in 164. The sensitivity of the 7MS for Alzheimer’s disease was 92.9% with a specificity of 93.5%. For other types of dementia the sensitivity was 89.4% and the specificity 93.5%. Cognitive abnormalities were found in 71% of the patients with depression (n = 31). The mean (SD) duration of administration of the 7MS was 12.4 (4.6) minutes, range 8 to 22, depending on dementia severity.

Conclusions: The 7MS is a useful screening tool for discriminating patients with dementia from cognitively intact patients. This not only applies to Alzheimer’s disease but also to other types of dementia. Specificity with respect to depression was lower for the 7MS than for the MMSE.


Keywords: Alzheimer’s disease; cognitive screen; dementia; depression

Abbreviations: ADRDA, Alzheimer’s Disease and Related Disorders Association; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th revision; MMSE, mini-mental state examination; NINDS, National Institute of Neurological and Communicative Disorders and Stroke; 7MS, seven minute screen




This article has been cited by other articles:


Home page
NeurologyHome page
J. Sundelof, J. Arnlov, E. Ingelsson, J. Sundstrom, S. Basu, B. Zethelius, A. Larsson, M. C. Irizarry, V. Giedraitis, E. Ronnemaa, et al.
Serum cystatin C and the risk of Alzheimer disease in elderly men
Neurology, September 30, 2008; 71(14): 1072 - 1079.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. R. Krull, M. F. Okcu, B. Potter, N. Jain, Z. Dreyer, K. Kamdar, and P. Brouwers
Screening for Neurocognitive Impairment in Pediatric Cancer Long-Term Survivors
J. Clin. Oncol., September 1, 2008; 26(25): 4138 - 4143.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Sundelof, V. Giedraitis, M. C. Irizarry, J. Sundstrom, E. Ingelsson, E. Ronnemaa, J. Arnlov, M. D. Gunnarsson, B. T. Hyman, H. Basun, et al.
Plasma {beta} Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men: A Prospective, Population-Based Cohort Study
Arch Neurol, February 1, 2008; 65(2): 256 - 263.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A D Hutchinson and J L Mathias
Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review
J. Neurol. Neurosurg. Psychiatry, September 1, 2007; 78(9): 917 - 928.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
B. Cullen, B. O'Neill, J. J Evans, R. F Coen, and B. A Lawlor
A review of screening tests for cognitive impairment
J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 790 - 799.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., September 1, 2004; 9(5): e5 - e5.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
V W Henderson
Detecting dementia in just 12 minutes: the seven minute screen
J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 666 - 667.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.